Inflammation  >>  fuzheng Huayu  >>  Phase 2
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove FilterRemove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
fuzheng Huayu / Shanghai Sundise
NCT00854087: Assess the Antifibrotic Activity of Fuzheng Huayu in Chronic Hepatitis C Patients With Hepatic Fibrosis

Completed
2
118
US
Fuzheng Huayu, Gan Ping, 319 Recipe, FZHY, Placebo
Tarek Hassanein, Shanghai Sundise Traditional Chinese Medicine Co., Ltd.
Chronic Hepatitis C Infection
04/13
08/13

Download Options